GNH USA

Europe — EMA

Nebivolol Medreg

GNH USA supplies Nebivolol Medreg (Nebivolol), a beta blocker for hypertension and heart failure, available to hospitals, pharmacies and clinics worldwide.

Nebivolol

Request sourcing

1
Pack/s

What is Nebivolol?

Nebivolol, the active ingredient in Nebivolol Medreg, is a beta blocker presented as a tablet for oral use. It treats hypertension and heart failure in adult patients. GNH USA supplies Nebivolol Medreg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Nebivolol used for?

Nebivolol is a selective β1‑adrenergic antagonist used in cardiovascular disease management.

Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk. Heart failure: improves left ventricular ejection fraction and alleviates symptoms in patients with reduced ejection fraction. Angina pectoris: decreases myocardial oxygen demand and relieves chest pain.

What are the side effects of Nebivolol?

Nebivolol may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or light‑headedness, especially on standing. - Fatigue or general weakness. - Nausea or abdominal discomfort. - Bradycardia: heart rate below 60 bpm. - Nasal congestion or rhinorrhoea.

Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Marked hypotension leading to syncope. - Acute bronchospasm in patients with asthma or COPD. - Allergic reactions such as rash, pruritus, or angio‑edema. - Hepatic enzyme elevation or liver injury. - Cardiogenic shock in patients with decompensated heart failure.

What precautions apply to Nebivolol?

Before initiating Nebivolol, clinicians should consider several safety factors.

Monitor blood pressure: check regularly during dose titration. Assess heart rate: watch for bradycardia, especially in patients with conduction disorders. Caution in asthma/COPD: beta‑blockade may worsen bronchospasm. Renal or hepatic impairment: dose adjustment may be required. Pregnancy and lactation: use only if potential benefits outweigh risks. Store at ambient temperature: keep below 25°C, protect from moisture and light.

What does Nebivolol interact with?

Nebivolol can interact with several medication classes.

Major Interactions (Avoid): - Concomitant use with other beta‑blockers: risk of excessive bradycardia. - Strong CYP2D6 inhibitors (e.g., paroxetine, quinidine): increase nebivolol plasma concentrations. - Calcium channel blockers verapamil or diltiazem: may enhance negative inotropic effect.

Moderate Interactions (Monitor Closely):\n- Non‑selective beta‑blockers: additive blood‑pressure lowering. - Diuretics: may precipitate orthostatic hypotension. - Other antihypertensives (ACE inhibitors, ARBs): monitor for symptomatic hypotension.

Frequently asked questions

What is Nebivolol Medreg used for?+
Nebivolol Medreg is prescribed to manage high blood pressure (hypertension) and to treat chronic heart failure in adult patients. By lowering systemic vascular resistance and improving cardiac output, it helps reduce the risk of cardiovascular events associated with these conditions.
How does Nebivolol work?+
Nebivolol selectively blocks β1‑adrenergic receptors, decreasing heart rate and contractility. At the same time, it stimulates endothelial nitric oxide release, causing vasodilation. This combined effect lowers blood pressure while supporting better blood flow without significant β2‑receptor blockade.
What is the usual dose of Nebivolol Medreg?+
The appropriate dose of Nebivolol Medreg is determined by the prescribing healthcare professional based on the individual’s clinical condition, response to therapy, and any co‑existing medical issues. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Nebivolol Medreg safe in pregnancy or breastfeeding?+
Nebivolol’s pregnancy category is listed as unknown. It should only be used during pregnancy or lactation when the potential benefits justify the possible risks to the fetus or infant. Healthcare providers must evaluate each case individually.
How do I order Nebivolol Medreg from GNH USA?+
To request Nebivolol Medreg, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Nebivolol compare with other beta blockers?+
Nebivolol is a highly β1‑selective blocker with additional nitric‑oxide‑mediated vasodilation, which can result in fewer metabolic side effects and better tolerance compared with non‑selective beta blockers. Its dual mechanism may offer superior blood‑pressure control while preserving peripheral circulation.
How should Nebivolol Medreg be stored and handled?+
Nebivolol Medreg tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children.
How is Nebivolol Medreg administered?+
Nebivolol Medreg is taken orally, usually once daily, with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.
What are the most serious risks to watch for while taking Nebivolol?+
Serious risks include severe bradycardia, marked hypotension, heart block, bronchospasm in patients with reactive airway disease, and rare allergic reactions such as angio‑edema. Patients should seek immediate medical attention if they experience fainting, rapid weight gain, swelling, or difficulty breathing.
Who should not use Nebivolol Medreg?+
Nebivolol is contraindicated in patients with known hypersensitivity to nebivolol or any excipients, those with severe bradycardia (heart rate <50 bpm), second‑ or third‑degree atrioventricular block without a pacemaker, and individuals with uncompensated heart failure or cardiogenic shock.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Nebivolol
Route
Oral Use
Manufacturer
Medreg S.R.O.
Origin
EU

Related products

Nebivolol 20 mg/1

Nebivolol 20 mg/1

Nebivolol · 20 mg

nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 2.5 mg/1

NEBIVOLOL 2.5 mg/1

Nebivolol · 2.5 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 5 mg/1

NEBIVOLOL 5 mg/1

Nebivolol · 5 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 10 mg/1

NEBIVOLOL 10 mg/1

Nebivolol · 10 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA